APA (7th ed.) Citation

Bender, H., Icks, A., & Dintsios, C. (2022). PCR12 Health-Related Quality of Life in German Early Benefit Assessment of Cancer Drugs: How Evidence-Based Are the Instruments Used? Value in Health, 25(12), S392. https://doi.org/10.1016/j.jval.2022.09.1947

Chicago Style (17th ed.) Citation

Bender, H., A. Icks, and CM Dintsios. "PCR12 Health-Related Quality of Life in German Early Benefit Assessment of Cancer Drugs: How Evidence-Based Are the Instruments Used?" Value in Health 25, no. 12 (2022): S392. https://doi.org/10.1016/j.jval.2022.09.1947.

MLA (9th ed.) Citation

Bender, H., et al. "PCR12 Health-Related Quality of Life in German Early Benefit Assessment of Cancer Drugs: How Evidence-Based Are the Instruments Used?" Value in Health, vol. 25, no. 12, 2022, p. S392, https://doi.org/10.1016/j.jval.2022.09.1947.